Literature DB >> 22847299

Liver: Transjugular liver biopsy yields high-quality samples.

Evangelos Cholongitas, Andrew K Burroughs.   

Abstract

Mesh：

Year:  2012        PMID： 22847299     DOI： 10.1038/nrgastro.2012.146

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Tolerance of liver biopsy in a tertiary care center: comparison of the percutaneous and the transvenous route in 143 prospectively followed patients.

Authors:  Bogdan Procopet; Christophe Bureau; Sophie Métivier; Janick Selves; Marie Angèle Robic; Camille Christol; Mircea Grigorescu; Jean-Pierre Vinel; Jean-Marie Péron
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 2.566

2.  Transjugular liver biopsy: how good is it for accurate histological interpretation?

Authors:  E Cholongitas; A Quaglia; D Samonakis; M Senzolo; C Triantos; D Patch; G Leandro; A P Dhillon; A K Burroughs
Journal:  Gut       Date:  2006-04-24       Impact factor: 23.059

3.  Hepatic venous pressure gradient in 2010: optimal measurement is key.

Authors:  Andrew K Burroughs; Ulrich Thalheimer
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 4.  A systematic review of the quality of liver biopsy specimens.

Authors:  Evangelos Cholongitas; Marco Senzolo; Richard Standish; Laura Marelli; Alberto Quaglia; David Patch; Amar P Dhillon; Andrew Kenneth Burroughs
Journal:  Am J Clin Pathol       Date:  2006-05       Impact factor: 2.493

5.  A comparison of four- versus three-pass transjugular biopsy using a 19-G Tru-Cut needle and a randomized study using a cassette to prevent biopsy fragmentation.

Authors:  Shusang Vibhakorn; Evangelos Cholongitas; George Kalambokis; Pinelopi Manousou; Alberto Quaglia; Laura Marelli; Marco Senzolo; David Patch; Amar Dhillon; Andrew K Burroughs
Journal:  Cardiovasc Intervent Radiol       Date:  2008-08-13       Impact factor: 2.740

Review 6.  Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review.

Authors:  George Kalambokis; Pinelopi Manousou; Shusang Vibhakorn; Laura Marelli; Evangelos Cholongitas; Marco Senzolo; David Patch; Andrew K Burroughs
Journal:  J Hepatol       Date:  2007-05-24       Impact factor: 25.083

Review 7.  Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Authors:  A K Burroughs; R Groszmann; J Bosch; N Grace; G Garcia-Tsao; D Patch; J C Garcia-Pagan; L Dagher
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

8.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.

Authors:  Guido Colloredo; Maria Guido; Aurelio Sonzogni; Gioacchino Leandro
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

9.  The normal adult human liver biopsy: a quantitative reference standard.

Authors:  A R Crawford; X Z Lin; J M Crawford
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425
  9 in total
  3 in total

1.  The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.

Authors:  Guiqiang Wang; Atsushi Tanaka; Hong Zhao; Jidong Jia; Xiong Ma; Kenichi Harada; Fu-Sheng Wang; Lai Wei; Qixia Wang; Ying Sun; Yuan Hong; Huiying Rao; Cumali Efe; George Lau; Diana Payawal; Rino Gani; Keith Lindor; Wasim Jafri; Masao Omata; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-05-04       Impact factor: 6.047

Review 2.  From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?

Authors:  Anna Sessa; Manon Allaire; Pascal Lebray; Mourad Medmoun; Alberto Tiritilli; Pierre Iaria; Jean-François Cadranel
Journal:  JHEP Rep       Date:  2021-01-27

3.  Bile leak after transjugular liver biopsy in a cholecystectomy patient.

Authors:  Omar Alharthi; Vahid Etezadi
Journal:  Radiol Case Rep       Date:  2018-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.